Effects of polymorphisms in β1-adrenoceptor and α-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study

Journal of Applied Physiology

Volumn 100, Issue 2, 2006, Pages 507-511

  Nieminen, Tuomo ^a   Lehtimäki, Terho ^b   Laiho, Jarno ^b   Rontu, Riikka ^b   Niemelä, Kari ^b   Kööbi, Tiit ^b   Lehtinen, Rami ^a,b   Viik, Jari ^a   Turjanmaa, Väinö ^b   Kähönen, Mika ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

1 adrenergic receptor; Genetic polymorphisms

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; EXERCISE TEST; FEMALE; GENOTYPE; HEART RATE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; FINLAND; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ANALYSIS OF VARIANCE; BLOOD PRESSURE; EXERCISE TEST; FEMALE; FINLAND; GENOTYPE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HEART RATE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-1;

EID: 33646384204     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00899.2005     Document Type: Article

References (26)

1. Abe M, Nakura J, Yamamoto M, Jin JJ, Wu Z, Tabara Y, Yamamoto Y, Igase M, Kohara K, and Miki T. Association of GNAS1 gene variant with hypertension depending on smoking status. Hypertension 40: 261-265, 2002.
2. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L, and Groop L. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 104: 187-190, 2001.
3. Borjesson M, Magnusson Y, Hjalmarson A, and Andersson B. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 21: 1853-1858, 2000.
4. Bouchard C and Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 33: 446-453, 2001.
5. Brodde OE. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43: 203-242, 1991.
6. Buscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S, Hoyer PF, Michel MC, Insel PA, and Brodde OE. In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 11: 199-205, 2001.
7. Chen Y, Nakura J, Jin JJ, Wu Z, Yamamoto M, Abe M, Tabara Y, Yamamoto Y, Igase M, Bo X, Kohara K, and Miki T. Association of the GNAS1 gene variant with hypertension is dependent on alcohol consumption. Hypertens Res 26: 439-444, 2003.
8. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL, Wallace MR, Lewis JF, McNamara DM, Picoult-Newberg L, Pepine CJ, and Johnson JA. Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 88: 1034-1037, 2001.
9. Jia H, Hingorani AD, Sharma P, Hopper R, Dickerson C, Trutwein D, Lloyd DD, and Brown MJ. Association of the G(s)alpha gene with essential hypertension and response to beta-blockade. Hypertension 34: 8-14, 1999.
10. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, and Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74: 44-52, 2003.
11. Leineweber K, Buscher R, Bruck H, and Brodde OE. Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 369: 1-22, 2004.
12. Levin MC, Marullo S, Muntaner O, Andersson B, and Magnusson Y. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277: 30429-30435, 2002.
13. Liggett SB. Polymorphisms of adrenergic receptors: variations on a theme. Assay Drug Dev Technol 1: 317-326, 2003.
14. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14: 143-149, 1999.
15. Mason DA, Moore JD, Green SA, and Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274: 12670-12674, 1999.
16. Molenaar P, Rabnott G, Yang I, Fong KM, Savarimuthu SM, Li L, West MJ, and Russell FD. Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 40: 1275-1282, 2002.
17. Newton GE, Azevedo ER, and Parker JD. Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study. Circulation 99: 2402-2407, 1999.
18. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, and Brown MJ. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 99: 233-238, 2000.
19. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, and Risch N. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70: 935-942, 2002.
20. Rathz DA, Brown KM, Kramer LA, and Liggett SB. Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39: 155-160, 2002.
21. Sandilands AJ, O'Shaughnessy KM, and Brown MJ. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138: 386-392, 2003.
22. Sarsero D, Russell FD, Lynham JA, Rabnott G, Yang I, Fong KM, Li L, Kaumann AJ, and Molenaar P. (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 367: 10-21, 2003.
23. Shioji K, Kokubo Y, Mannami T, Inamoto N, Morisaki H, Mino Y, Tagoi N, Yasui N, and Iwaii N. Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res 27: 31-37, 2004.
24. Small KM, McGraw DW, and Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43: 381-411, 2003.
25. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA, Prasad HC, Byrne DW, Nair UB, Wood AJ, and Stein CM. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 73: 366-371, 2003.
26. Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, and Stein CM. Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11: 191-197, 2001.